| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a7ac31dafa9b644bcbf73f79c4695dc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00 |
| filingDate |
2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61ebcaab6f43c1fd0405d8d346f33ee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e84d131de3c5c76a195898ee7e035944
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c05c8715e4c048525655f87e4c05ce26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a99a045e0e782aa7ef0243ec1c2efd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_829f424ffa02dc1eee2e4dbb1168b6b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f804e8ee1d2ebed25cb8eaecb2c89a |
| publicationDate |
2021-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3902533-A1 |
| titleOfInvention |
Inhibiting ubiquitin specific peptidase 9x |
| abstract |
The disclosure provides novel chemical compounds useful as inhibitors of ubiquitin specific peptidase 9X (USP9X). USP9X inhibiting compounds are useful in the treatment of disease and disorders associated with modulation of USP9X, such as cancer. |
| priorityDate |
2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |